BTC comments
This article was originally published in The Tan Sheet
Executive Summary
FDA clarifies the comment period regarding behind-the-counter availability of some nonprescription drugs continues through Dec. 17, the agency says in a Nov. 27 Federal Register notice. The docket for comments on the topic will remain open for 30 days following the meeting FDA conducted Nov. 14 to obtain comments on BTC availability, but in its Oct. 4 notice announcing the meeting, the agency incorrectly listed the deadline as Nov. 28....